arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

PACS Group, Inc.

PACS Health Care Hospital/Nursing Management
$42.50
▲ +0.0% Today
as of Sep 4, 16:52 ET
Last 30 days -9.73% Jul 27 → Sep 04
$41.64 $43.47 $45.30 $47.12 $48.95 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$42.61
High
$43.16
Low
$42.11
Volume
$649,460
Avg Vol
$1M
Mkt Cap
$7.3B
P/E (TTM)
33.14
Beta
—
52w High
$49.49
52w Low
$7.50
Div Yield
—
Shares Out
$158M

Recent Press Releases & News last 60 days · 25 items

Sep 4 · 07:56 MT Newswires
PACS Group Insider Sold Shares Worth $2,903,753, According to a Recent SEC Filing
Sep 2 · 18:46 MT Newswires
PACS' Florida Deal Supports Market Expansion, UBS Says
Sep 2 · 13:58 InvestorsHub
PACS Group Shares Rise 3.3% as Company Plans Florida Expansion and Completes More Eduro Acquisitions
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$7.50
$49
83% of range
Avg surprise (last 1)
+19.1%
Avg reaction (last 1)
-5.0%
0% positive
Latest IV / EM
58%
EM ±9.1% · $45 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.10$0.20$0.30$0.40$0.50 Actual $0.16Actual $0.15Actual $0.10Actual $0.17Actual $0.31Actual $0.32Actual $0.50Est $0.42Actual $0.47 JunSepSepMarJunSepMar/2026Jun
Revenue vs Net Income Revenue Net income
$0$375M$750M$1.1B$1.5B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.47 — — — — financials
Mon May 11, 2026Mar/2026 $0.50 $0.42 +19.1% — -5.0% earnings
Tue Sep 30, 2025Sep 2025 $0.32 — — — — financials
Mon Jun 30, 2025Jun 2025 $0.31 — — — — financials
Mon Mar 31, 2025Mar 2025 $0.17 — — — — financials
Mon Sep 30, 2024Sep 2024 $0.10 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.15 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.16 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$1.43B$1.42B—$1.34B$1.31B$1.28B—$1.03B
Cost of revenue———————$850M
Gross profit————————
Operating income$109M$120M—$86M$80M$48M—$23M
Net income$76M$81M—$52M$51M$28M—$16M
EPS (diluted)$0.47$0.50—$0.32$0.31$0.17—$0.10

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$164M$248M$197M$356M$294M$288M$158M$50M
Inventory————————
Total current assets$962M$1.07B$1.07B$1.13B$1.08B$1.08B$938M$735M
Total assets$5.66B$5.66B$5.58B$5.63B$5.50B$5.49B$5.24B$4.52B
Long-term debt$239M$240M$245M$246M$247M$249M$251M$254M
Total liabilities$4.54B$4.62B$4.63B$4.75B$4.69B$4.74B$4.53B$3.85B
Total equity$1.11B$1.04B$947M$871M$813M$756M$710M$660M

Implied volatility — last 90 days

44%75%105%135%165% Jun 07 — IV 75% · EM ±10.4%Jun 08 — IV 62% · EM ±8.2%Jun 09 — IV 70% · EM ±8.7%Jun 10 — IV 88% · EM ±10.3%Jun 11 — IV 63% · EM ±7.0%Jun 12 — IV 63% · EM ±6.4%Jun 15 — IV 72% · EM ±5.2%Jun 16 — IV 91% · EM ±5.4%Jun 17 — IV 73% · EM ±3.1%Jun 19 — IV 59% · EM ±13.0%Jun 22 — IV 64% · EM ±13.4%Jun 23 — IV 63% · EM ±12.9%Jun 24 — IV 63% · EM ±12.6%Jun 25 — IV 61% · EM ±12.0%Jun 26 — IV 69% · EM ±13.2%Jun 29 — IV 63% · EM ±11.2%Jun 30 — IV 60% · EM ±10.4%Jul 01 — IV 66% · EM ±11.0%Jul 02 — IV 59% · EM ±9.5%Jul 03 — IV 60% · EM ±9.4%Jul 06 — IV 61% · EM ±8.4%Jul 07 — IV 67% · EM ±8.9%Jul 08 — IV 56% · EM ±7.0%Jul 09 — IV 55% · EM ±6.5%Jul 10 — IV 166% · EM ±18.3%Jul 13 — IV 90% · EM ±7.5%Jul 14 — IV 71% · EM ±5.2%Jul 15 — IV 68% · EM ±4.0%Jul 16 — IV 91% · EM ±3.8%Jul 20 — IV 76% · EM ±17.9%Jul 21 — IV 84% · EM ±19.5%Jul 22 — IV 82% · EM ±18.9%Jul 23 — IV 78% · EM ±17.5%Jul 24 — IV 80% · EM ±17.7%Jul 27 — IV 92% · EM ±19.2%Jul 28 — IV 88% · EM ±17.9%Jul 29 — IV 77% · EM ±15.4%Jul 30 — IV 78% · EM ±15.3%Jul 31 — IV 88% · EM ±16.8%Aug 03 — IV 88% · EM ±15.6%Aug 04 — IV 90% · EM ±15.5%Aug 05 — IV 60% · EM ±10.0%Aug 06 — IV 60% · EM ±9.8%Aug 07 — IV 61% · EM ±9.6%Aug 10 — IV 57% · EM ±7.8%Aug 11 — IV 59% · EM ±7.8%Aug 12 — IV 53% · EM ±6.7%Aug 13 — IV 45% · EM ±5.3%Aug 14 — IV 50% · EM ±5.6%Aug 17 — IV 68% · EM ±5.6%Aug 18 — IV 62% · EM ±4.5%Aug 19 — IV 99% · EM ±5.9%Aug 20 — IV 157% · EM ±6.5%Aug 24 — IV 51% · EM ±10.7%Aug 25 — IV 47% · EM ±9.6%Aug 26 — IV 49% · EM ±9.9%Aug 27 — IV 53% · EM ±10.5%Aug 28 — IV 45% · EM ±8.6%Aug 31 — IV 58% · EM ±10.3%Sep 01 — IV 56% · EM ±9.6%Sep 02 — IV 51% · EM ±8.5%Sep 03 — IV 56% · EM ±9.0%Sep 04 — IV 58% · EM ±9.1%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in